A Vaya

Summary

Country: Spain

Publications

  1. request reprint
    Vaya A, Santaolaria M, Micó L, Calvo J, Oropesa R, Villa P, et al. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects. Clin Hemorheol Microcirc. 2008;40:79-87 pubmed
    ..142, P=0.233, respectively). In addition inherited thrombophilic risk factors AT, PC, PS deficiencies, factor V Leiden and PT G20210A mutation do not seem to increase thrombotic risk in SLE patients. ..
  2. request reprint
    Vaya A, Martinez Triguero M, Reganon E, Vila V, Martinez Sales V, Sola E, et al. Erythrocyte membrane composition in patients with primary hypercholesterolemia. Clin Hemorheol Microcirc. 2008;40:289-94 pubmed
    ..Therefore, a simple and reproducible method needs to be standardised which would enable comparisons between laboratories and facilitate further studies aimed to it as a marker of acute coronary syndromes. ..
  3. Vaya A, Plumé G, Bonet E, Carrasco P, Morales Suarez Varela M. Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis. Eur J Haematol. 2011;86:167-72 pubmed publisher
    ..404), controls (P =0.178), or in the different SVT subtypes (P =0.495). Our results suggest that HH and the homozygous genotype in the MTHFR C677T mutation do not seem to play a role in SVT development. ..

Detail Information

Publications3

  1. request reprint
    Vaya A, Santaolaria M, Micó L, Calvo J, Oropesa R, Villa P, et al. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects. Clin Hemorheol Microcirc. 2008;40:79-87 pubmed
    ..142, P=0.233, respectively). In addition inherited thrombophilic risk factors AT, PC, PS deficiencies, factor V Leiden and PT G20210A mutation do not seem to increase thrombotic risk in SLE patients. ..
  2. request reprint
    Vaya A, Martinez Triguero M, Reganon E, Vila V, Martinez Sales V, Sola E, et al. Erythrocyte membrane composition in patients with primary hypercholesterolemia. Clin Hemorheol Microcirc. 2008;40:289-94 pubmed
    ..Therefore, a simple and reproducible method needs to be standardised which would enable comparisons between laboratories and facilitate further studies aimed to it as a marker of acute coronary syndromes. ..
  3. Vaya A, Plumé G, Bonet E, Carrasco P, Morales Suarez Varela M. Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis. Eur J Haematol. 2011;86:167-72 pubmed publisher
    ..404), controls (P =0.178), or in the different SVT subtypes (P =0.495). Our results suggest that HH and the homozygous genotype in the MTHFR C677T mutation do not seem to play a role in SVT development. ..